ELEV: Elevation Oncology, Inc. Stock

by  •  • Comments Off on ELEV: Elevation Oncology, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 46.14
Enterprise Value ($M) 28.96
Book Value ($M) 69.36
Book Value / Share 1.17
Price / Book 0.67
NCAV ($M) 68.38
NCAV / Share 1.16
Price / NCAV 0.67

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.77

Liquidity (mrq)
Quick Ratio 17.77
Current Ratio 17.77

Balance Sheet (mrq) ($M)
Current Assets 105.32
Assets 106.30
Liabilities 36.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Orbimed Advisors Llc 4.00 -18.62
11-14 13G/A Logos Global Management LP 5.90 -4.11
11-14 13G/A Point72 Asset Management, L.P. 0.80 -87.62
11-14 13G/A Biotechnology Value Fund L P 9.99 39.99
11-14 13G/A Great Point Partners Llc 0.00 -100.00
11-12 13G/A Vanguard Group Inc 5.19 0.00
11-12 13G/A Aisling Capital IV, LP 4.92 1.21
11-08 13G/A Farallon Capital Partners, L.P. 6.00 13.79
11-06 13G Goldman Sachs Group Inc 7.60
10-09 13G/A Empery Asset Management, LP 4.99 40.83
08-08 13D/A venBio Global Strategic Fund III, L.P. 3.40 -19.93
07-15 13G/A Frazier Life Sciences Public Fund, L.P. 11.00 102.58
02-14 13G/A K2 HealthVentures Equity Trust LLC 4.00 13.90
02-14 13G/A Cormorant Asset Management, LP 0.00 -100.00
02-14 13G/A Tang Capital Partners Lp 9.99 217.18
02-07 13G/A ExodusPoint Capital Management, LP 0.10 -96.47
01-31 13G/A Integrated Core Strategies (us) Llc 7.10 113.99
2024-01-09 13G/A Qiming U.S. Healthcare GP II, LLC 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 981,586 2,672,555 36.73
2025-01-14 1,904,394 5,342,358 35.65
2025-01-13 15,070,827 37,176,690 40.54
2025-01-10 493,820 1,749,912 28.22

(click for more detail)

Similar Companies
DSGN – Design Therapeutics, Inc. DVAX – Dynavax Technologies Corporation
EDIT – Editas Medicine, Inc. ELVN – Enliven Therapeutics, Inc.
ENTA – Enanta Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io